Strategic expansion will meet increasing global demand for biopharmaceutical development and manufacturing
COPENHAGEN, Denmark and BOTHELL, Wash.,
Aug. 22, 2018 /PRNewswire/ -- AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today that as part of its global expansion strategy, the company is increasing manufacturing capacity at its Copenhagen, Denmark facility.
